Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, February 01, 2015
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Shimadzu Launches Nexera UC
Thursday, January 29, 2015
Nexera Unified Chromatography system showcases complete automation and combines automatic sample pre-treatment with chromatographic separation and analysis.

Entry Level Microplate Solvent Evaporator
Tuesday, January 27, 2015
Porvair’s MiniVap™ blowdown evaporator takes just minutes to remove volatile organic solvents.

HT2800T All-in-Ones GC Autosampler from HTA
Tuesday, January 27, 2015
Smart technologies for the best user experience.

Learn How BioTek Solutions Can Transform Research at SLAS 2015
Saturday, January 24, 2015
Company will showcase their newest innovations at the SLAS 2015 Conference and Exhibition in Washington DC.

UK Biobank Selects Trinean’s DropSense96™
Wednesday, January 14, 2015
DropSense96™ droplet reader selected for DNA quantitation throughout its Genotyping project.

New 50 Microliter Electronic Pipettes
Tuesday, January 13, 2015
New models deliver optimized precision pipetting in the volume range of 2 - 50 µl.

Agilent Introduces Microarray for Rapid Screening of Aneuploidy in Single Cells
Tuesday, January 13, 2015
Total time from assay to analysis reduced to less than eight hours.

Bio-Rad Introduces the ddPCR™ KRAS Screening Multiplex Kit for Cancer Research
Monday, January 12, 2015
latest offering in the company’s Droplet Digital™ PCR line of predesigned, fully wet-lab validated assays.

Bioo Scientific Releases 18S ITS rRNA Library Prep Kit
Saturday, January 10, 2015
The NEXTflex™ 18S ITS Amplicon-Seq kit simplify eukaryotic metagenomic studies.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 2625
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn